How Do Nootropics Differ from Amphetamines?
You’ve seen both words used for the same pill. That’s the first problem.
The second is that the difference isn’t just a matter of strength. It’s a matter of what each one is, what the evidence says, and what it can cost you.
Key Takeaways
- Amphetamines are prescription stimulants. Evekeo’s label lists ADHD, narcolepsy and short-term use for exogenous obesity, and classes it as a Schedule II controlled substance
- The label carries a boxed warning. It says Evekeo has a high potential for abuse and misuse, which can lead to a substance use disorder, including addiction
- The evidence in healthy adults is modest. A 2020 meta-analysis found no overall effect for d-amphetamine, and a 2015 one found small effects at best
- Nootropic is not a synonym for safe. Most popular smart drugs are stimulants, and plenty of supplement-style nootropics have thin evidence in healthy people
- Your starting point is your own profile. Name your bottleneck before you name a compound, and keep a doctor in the loop
What Are Amphetamines, Exactly?
Amphetamines are central nervous system stimulants. Doctors prescribe them for conditions where attention, wakefulness or impulse control are impaired.
Take Evekeo, a brand-name amphetamine. Its prescribing information lists ADHD in children aged 3 and up, narcolepsy, and a short-term role for exogenous obesity alongside calorie restriction.
The same label says Evekeo is a Schedule II controlled substance. That’s a federal category for tightly controlled drugs, and it matters for everything that follows.
What Counts as a Nootropic?
Here the answer gets slippery. People use the word for everything from caffeine to racetams to herbs to prescription drugs, and no single definition holds all of them.

A 2022 review in Drugs makes the point plainly. Most of the popular cognitive enhancers are stimulants, and their effect in healthy people is uncertain and often temporary.
So the old line that nootropics are gentle and stimulants are harsh doesn’t survive contact with the research. Some compounds sit in both camps, and caffeine is the everyday example.
Do Amphetamines Make Healthy Brains Smarter?
Start with the evidence. A 2020 meta-analysis of healthy, non-sleep-deprived adults found no overall effect for d-amphetamine, a small effect for methylphenidate (SMD 0.21) and a smaller one for modafinil (SMD 0.12).

The authors called the data far from positive, and noted a gap between what users believe and what trials show. A 2015 meta-analysis of 48 studies found small effects on inhibitory control and short-term memory, and suggested healthy users may be after energy and motivation more than cognition.
That’s the honest profile. Stimulants help people whose attention is impaired, and the case for healthy adults is far weaker.
How Do the Risks Compare?
Start with what the Evekeo label reports. Common adverse reactions include headache, stomach discomfort, trouble sleeping, nervousness, dry mouth, reduced appetite and mood changes.
The label lists use with MAOIs as a contraindication, warns against use in people with serious cardiac disease, and urges caution with hypertension. A 2025 JAMA Network Open meta-analysis of 93 trials found stimulants carried a higher risk of adverse events than placebo (RR 1.34).
Supplement-style nootropics are not automatically safer. A 2022 study in Clinical Toxicology tested seven cognitive-enhancement supplements sold in the US, and only one of seven listed the centrophenoxine amount within 10 percent of what was actually inside.
Dose accuracy and evidence both vary by product. For the full tour of what can go wrong, read our nootropic safety guide and our piece on risks and side effects.
What About Coffee?
Coffee is a stimulant, and people argue about whether it’s a nootropic. The label matters less than the dose and your body.
Mayo Clinic says up to 400 mg of caffeine a day seems safe for most adults, and that caffeine can worsen anxiety. Crashes, jitters and poor sleep are your cue to scale back.
How Do You Pick Your Starting Point?
This is where the self-inventory comes in. Ask what your bottleneck is before you ask what to take.
- Is it sleep, stress, distraction or a possible attention disorder?
- Have you built the foundation: sleep, food, movement and a work routine?
- Would you describe your goal as treatment of a problem or enhancement of normal performance?
If you suspect ADHD, get evaluated by a clinician. Sharing or borrowing a prescription stimulant is not a workaround, because the label itself warns about diversion, and it can harm the person who takes a drug that wasn’t prescribed to them.
For the bigger picture, see our comparisons of prescription and natural nootropics and prescription and over-the-counter nootropics. Our guide on whether smart drugs are a good idea covers the decision itself.
Still wondering? These are the questions readers send most.
Your Next Step: Name Your Bottleneck Before You Name a Drug
Write down what actually slows you down, and for how long, before you search for anything to take.
That one page of notes will tell you more about your next move than any label or forum ever will.

